Related Experiment Video
Updated: May 30, 2026
05:52
Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster
Published on: June 30, 2011
Insulin administration: selecting the appropriate needle and individualizing the injection technique
Birtha Hansen1, Irina Matytsina
1Aarhus University Hospital, Medical Endocrinology Department MEA, Noerrebrogade 44, 8000 Aarhus C, Denmark. bh@ki.au.dk
Expert Opinion on Drug Delivery
|August 26, 2011
Summary
Optimal insulin injection technique and needle selection are crucial for patients with diabetes to achieve glycemic control. Shorter needles (under 8 mm) are generally recommended, but individual factors influence the best choice for effective insulin therapy.
Area of Science:
- Endocrinology
- Diabetes Management
- Pharmacology
Background:
- Many patients with diabetes on insulin therapy struggle to achieve metabolic control.
- Suboptimal glycemic control is often linked to improper insulin injection techniques.
Purpose of the Study:
- To review current data on insulin injection practices and needle characteristics.
- To explore the impact of injection technique and needle choice on patient satisfaction and glycemic control.
Main Methods:
- A literature review of Medline and Cumulative Index to Nursing and Allied Health Literature databases.
- Analysis of data concerning insulin injection, needle characteristics, and patient outcomes.
Main Results:
- Appropriate insulin injection techniques and needle selection can improve glycemic control in both pediatric and adult patients.
- Needles shorter than 8 mm are generally suitable for most patients, regardless of weight.
- Factors such as BMI, gender, race, age, and injection site influence subcutaneous tissue depth and optimal needle size/technique.
- Abdominal injection sites lead to slightly faster insulin dispersion compared to thigh injections.
Conclusions:
- Further evidence on the safety and efficacy of needles shorter than 6 mm, especially in children, is needed for wider adoption.
- Future developments may focus on even shorter and thinner needles to enhance injection ease and patient comfort.
Related Concept Videos
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...